A federal appeals court this week upheld a ruling that Becton Dickinson (NYSE:BDX) owes nothing more in a long-running false advertising claims case brought by Retractable Technologies (NYSE:RVP). The dispute dates back to 2001, when Little Elm, Texas-based RTI sued BD for patent infringement; that case settled for $100 million in 2004. RTI sued again barely three years […]
Medical device cybersecurity: It’s time to get real
Medical device makers, regulators and healthcare delivery organizations are increasingly working together to strengthen cybersecurity. But are they doing enough? Almost no one in the medtech industry disputes the vulnerability posed by cyberattacks. How to go about boosting security is another matter – one on which those stakeholders have recently stepped up their collaboration. One […]
FDA approves BD’s Venovo venous stent
Becton Dickinson & Co. (NYSE:BDX) said today that the FDA granted pre-market approval for its Venovo stent for treating iliofemoral venous occlusive disease. Franklin Lakes, N.J.-based BD touted Venovo as the first on the U.S. market approved to treat obstructed blood flow in the iliac and femoral veins. “The FDA pre-market approval of the Venovo venous […]
BD’s Bard pulls all pelvic mesh products from EU market
Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard is removing its women’s pelvic organ prolapse and stress urinary incontinence mesh devices from the European Market, according to a recently posted field corrective action from the company. The Murray Hill, N.J.-based company said that it is “initiating a cease in production and distribution of these devices and a […]
Becton Dickinson wins FDA 510(k) for Wavelinq 4F endoAVF system
Becton Dickinson (NYSE:BDX) said today that it won FDA 510(k) clearance for its WavelinQ 4 French endovascular arteriovenous fistula creation system. The Franklin Lakes, N.J.-based company said that the newly cleared WavelinQ 4F endoAVF system features improved technology that allows for the creation of an AVF in either the ulnar artery and ulnar vein or the radial […]
Becton Dickinson posts Street-topping FY2019 Q1 earnings
Becton Dickinson (NYSE:BDX) today posted fiscal year 2019 first quarter earnings that topped expectations on Wall Street, while share prices dipped slightly. The Franklin Lakes, N.J.-based company posted profits of $562 million, or $2.05 per share, on sales of $4.16 billion for the three months ended December 31, seeing a swing back into black ink on […]
Becton Dickinson’s fiscal Q1 prelims beat The Street
Becton Dickinson (NYSE:BDX) beat the consensus forecast on Wall Street today with its preliminary fiscal 2019 first quarter results and confirmed its outlook for the rest of fiscal 2019. The Franklin Lakes, N.J.-based healthcare giant said it expects to post adjusted earnings per share of $2.70 on sales of $4.16 billion for the three months ended Dec. […]
Becton Dickinson’s Q4 meets earnings expectations, beats on revenue
Becton Dickinson & Co. (NYSE:BDX) today met the consensus earnings forecasts and beat revenue expectations for both its fiscal fourth-quarter and full-year results, despite a Q4 swing to red. The Franklin Lakes, N.J.-based healthcare giant posted losses of -$173 million, or -64¢ per share, on sales of $4.40 billion for the three months ended Sept. 30, […]
LeMaitre Vascular puts up $2m for BD’s Cardial
LeMaitre Vascular (NSDQ:LMAT) said today it inked a deal to acquire Becton Dickinson‘s (NYSE:BDX) Cardial subsidiary for approximately $2.3 million (EU €2 million). The Saint-Étienne, France-based subsidiary produces knitted and woven vascular grafts, valvulotomes and surgical glue, and reported approximately $3.3 million (EU €2.9 million) in sales over the past 12 months, Burlington, Mass.-based LeMaitre said. […]
FDA releases BD lock flush syringe facility warning letter
The FDA this week released a warning letter it sent to Becton Dickinson (NYSE: BDX) last month over issues it found at the company’s Franklin, Wisc.-based facilities, which produces pre-filled Heparin and 0.9% sodium chloride lock flush syringes. The warning letter came from an inspection of the facilities which took place between May 16, 2018 and August […]
BD uses Carbon’s 3D tech to mold intricate part
Becton, Dickinson and Company (BD) has begun producing parts based on Carbon’s digital light synthesis technology, including BD’s first production part using additive manufacturing — a hemocytometer adapter for the company’s Rhapsody single-cell genomic analysis system. This component would have been impractical and expensive to injection mold, according to Redwood City, Calif.–based Carbon, which said it offered […]
- 1
- 2
- 3
- …
- 30
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube